Trial Profile
Phase 1, Randomized, Patient And Investigator-blind, Placebo-controlled Study To Investigate The Safety, Tolerability, Pharmacokinetics And Pharmacodynamics Of Multiple Intravenously Administered Doses Of Pf-04236921 In Patients With Rheumatoid Arthritis Receiving Methotrexate
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 09 Nov 2021
Price :
$35
*
At a glance
- Drugs TOUR-006 (Primary)
- Indications Rheumatoid arthritis
- Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
- 28 Mar 2012 Actual end date (Feb 2012) added as reported by ClinicalTrials.gov.
- 28 Mar 2012 Actual initiation date changed from June 2009 to May 2009 and actual patient number is 41 as reported by ClinicalTrials.gov.
- 28 Mar 2012 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.